Loerop James
- SEC CIK
- 0001781549
No open-market purchases or sales filed in the past year.
Current role at each company
- ACRS Aclaris Therapeutics, Inc.Chief Business Officeras of Feb 6, 2026
- ANIK Anika Therapeutics, Inc.EVP Business Developmentas of Jul 12, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Loerop James as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ACRS Aclaris Therapeutics, Inc.
Chief Business Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2023 (view filing) | Aug 28 | Same day | Loerop JamesChief Business Officer | PPurchase | +14.7K | $6.80 | +$100.0K | +210.6%21.7K after | |
| Feb 10, 2023 (view filing) | Feb 8 | 2 days | Loerop JamesChief Business Officer | SSale | −4.27K | $13.89 | −$59.3K | −37.9%6.98K after |